CN1629303A - Enzymatic synthesis method for L-ascorbic acid unsaturated fatty acid ester - Google Patents
Enzymatic synthesis method for L-ascorbic acid unsaturated fatty acid ester Download PDFInfo
- Publication number
- CN1629303A CN1629303A CN 200410053976 CN200410053976A CN1629303A CN 1629303 A CN1629303 A CN 1629303A CN 200410053976 CN200410053976 CN 200410053976 CN 200410053976 A CN200410053976 A CN 200410053976A CN 1629303 A CN1629303 A CN 1629303A
- Authority
- CN
- China
- Prior art keywords
- unsaturated fatty
- acid ester
- fatty acid
- xitix
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims abstract description 46
- -1 L-ascorbic acid unsaturated fatty acid ester Chemical class 0.000 title claims abstract description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 4
- 239000002211 L-ascorbic acid Substances 0.000 title abstract 4
- 235000000069 L-ascorbic acid Nutrition 0.000 title abstract 4
- 229960005070 ascorbic acid Drugs 0.000 title abstract 4
- 238000001308 synthesis method Methods 0.000 title abstract 2
- 230000002255 enzymatic effect Effects 0.000 title description 3
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 18
- 102000004190 Enzymes Human genes 0.000 claims abstract description 17
- 108090000790 Enzymes Proteins 0.000 claims abstract description 17
- 239000012429 reaction media Substances 0.000 claims abstract description 5
- 238000007796 conventional method Methods 0.000 claims abstract description 4
- 108090001060 Lipase Proteins 0.000 claims description 17
- 102000004882 Lipase Human genes 0.000 claims description 17
- 239000004367 Lipase Substances 0.000 claims description 17
- 235000019421 lipase Nutrition 0.000 claims description 17
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 17
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 239000002808 molecular sieve Substances 0.000 claims description 8
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 8
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 claims description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 6
- 238000010189 synthetic method Methods 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 5
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 claims description 5
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 5
- 229960004232 linoleic acid Drugs 0.000 claims description 5
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 claims description 4
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 claims description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 4
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 claims description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 4
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 claims description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000005642 Oleic acid Substances 0.000 claims description 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 238000009834 vaporization Methods 0.000 claims description 4
- 230000008016 vaporization Effects 0.000 claims description 4
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 claims description 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 3
- 235000021342 arachidonic acid Nutrition 0.000 claims description 3
- 229940114079 arachidonic acid Drugs 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 2
- 230000009429 distress Effects 0.000 claims description 2
- TYLNXKAVUJJPMU-UHFFFAOYSA-N ethyl docosa-2,4,6,8,10,12-hexaenoate Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(=O)OCC TYLNXKAVUJJPMU-UHFFFAOYSA-N 0.000 claims description 2
- 229940031016 ethyl linoleate Drugs 0.000 claims description 2
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 claims description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 2
- 229940093471 ethyl oleate Drugs 0.000 claims description 2
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 claims description 2
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 claims description 2
- 230000004044 response Effects 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 2
- 239000003054 catalyst Substances 0.000 abstract 1
- 230000002366 lipolytic effect Effects 0.000 abstract 1
- 239000000376 reactant Substances 0.000 abstract 1
- 238000006555 catalytic reaction Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000005303 weighing Methods 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 108010084311 Novozyme 435 Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000005809 transesterification reaction Methods 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010701 ester synthesis reaction Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000288105 Grus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001661345 Moesziomyces antarcticus Species 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses an snzymatic synthesis method for L-ascorbic acid unsaturated fatty acid ester which comprises the steps of, using immobilization lipolytic enzyme as catalyst in reaction medium for the L-ascorbic acid unsaturated fatty acid ester in the reaction system, then collecting L-ascorbic acid unsaturated fatty acid ester from the reactant through the conventional methods. The process provided by the invention can achieve high conversion rate within a short period of reaction time.
Description
Technical field
The present invention relates to a kind of preparation method of L-xitix unsaturated fatty acid ester, be specifically related to a kind of L-xitix unsaturated fatty acid ester enzyme and urge synthetic method.
Technical background
L-xitix (Vc) is a kind of natural anti-reflecting oxide of widespread use, is one of human indispensable nutritive factor.It is (reactive oxygen species, inhibitor ROS), and the generation of ROS and various diseases is closely related of active oxidation material in the organism.
Unsaturated fatty acids such as arachidonic acid AA, linolenic acid ALA, can not synthesize in the human bodies such as timnodonic acid EPA and docosahexenoic acid DHA, need from food, absorb, so be human indispensable fatty acid, they have physiological function and biological effect more widely in body, and two keys the more, degree of unsaturation is higher, nutritive value is also higher, and unsaturated fatty acids has the 26S Proteasome Structure and Function of biometric safeguard film, the treatment cardiovascular disorder, anti-inflammatory, anticancer and promote brain development, fat-reducing, physiological functions such as farrowing rate of increase animal and surviving rate.
For L-xitix palmityl ester function, particularly Antioxidation Effects, Recent study is a lot, and people such as Jian-Wen Liu report this kind material because of its antioxygenation, thus the transfer of anticancer.
With respect to L-xitix palmityl ester, L-xitix unsaturated fatty acid ester nonaqueous phase enzyme urges study on the synthesis few at home and abroad.Unsaturated fatty acids widespread use in makeup, medicine, food; itself just has the character of oxidation protection; if it is connected with Vc; to give new molecule better character; than the bad hematic acid palmityl of anti-L-ester; the easier permeate through cell membranes of L-xitix unsaturated fatty acid ester; in lipid layer, distribute easilier; ROS there is stronger restraining effect; studies show that of early stage, L-xitix unsaturated fatty acid ester have extraordinary two-phase solvability, strong anti-oxidation protection effect etc.Again because unsaturated fatty acids and palmitinic acid are bigger in aspect difference such as physicochemical property such as solvabilities, therefore its synthesis mechanism and technology urge synthesizing with the enzyme of L-xitix palmityl ester very big difference, and the enzyme of L-xitix palmityl ester urges synthetic method can not be used for L-xitix unsaturated fatty acid ester.
The nonaqueous phase enzyme catalysis is a research field that develops rapidly, since Zaks andKlibanov in 1984 research be reported in can carry out the catalyzed reaction of enzyme in the nonaqueous phase since, research to the nonaqueous phase enzymic catalytic reaction has obtained a large amount of progress, lipase is a kind of enzyme that is most widely used in the nonaqueous phase enzyme catalysis research, the lipase kind is a lot, its function difference of lipase that the different sources different microorganisms produces, its catalytic transesterification and ester synthesis reaction respectively have characteristics.
At present, the synthetic method of L-xitix unsaturated fatty acid ester generally adopts as Journal ofMolecular Catalysis B:Enzymatic, 5 (1998) 19-23 document disclosed methods, therefore this method reaction conversion rate of fatty acid less than 20% can not satisfy the needs of the parties concerned.
Summary of the invention
The technical issues that need to address of the present invention are to disclose a kind of L-xitix unsaturated fatty acid ester enzyme to urge synthetic method, to overcome the above-mentioned defective that prior art exists, satisfy the needs of relevant field development.
The present invention synthesizes corresponding ester by enzymic catalytic reaction with unsaturated fatty acids and the reaction of L-xitix, and it is water-soluble that this ester can be stablized, thereby can add this anthropoid important nutritive substance of unsaturated fatty acids in water-soluble drink and food.
The general structure of said L-xitix unsaturated fatty acid ester is as follows:
R represents C
17H
33, C
17H
31, C
17H
29, C
19H
31, C
19H
29Or C
21H
31
Method of the present invention comprises the steps:
With L-xitix and unsaturated fatty acids or unsaturated fatty acid ester, in reaction medium, with the immobilized lipase is catalyzer, in the reaction system, water-content is 0.01～0.06% by weight, 40～60 ℃ were reacted 1～16 hour, adopted conventional method to collect L-xitix unsaturated fatty acid ester then from reaction product.
Preferable methods of the present invention comprises the steps:
With L-xitix and unsaturated fatty acids or unsaturated fatty acid ester, in reaction medium, with the immobilized lipase is catalyzer, in the reaction system, water-content is 0.04%-0.06% by weight, 40～60 ℃ of reactions 1～3 hour, and then be reaction 8-16 hour under 0.01～0.04% the condition at water-content, adopt conventional method from reaction product, to collect L-xitix unsaturated fatty acid ester.
The control of water-content can realize that in the gross weight of L-xitix and unsaturated fatty acids or unsaturated fatty acid ester, the add-on of molecular sieve is 5～20wt% by add molecular sieve in reaction system;
Or the moisture content in the dry backflow hierarchy of control of employing reduction vaporization.
Term " reduction vaporization is dry to reflux " refers to reactor pressure and reduces, the evaporation of reaction solvent entrapped moisture, and through condensation, through the siccative drying, moisture is absorbed when flowing back to.Vacuum-pumping at vacuum tightness 0.08～0.1Mpa, makes the moisture evaporation in the system with the pressure-controlling of system, the condensation after drying, and the solvent partial reflux is to reach the purpose of water-content in the hierarchy of control.
The mol ratio of L-xitix and unsaturated fatty acids or unsaturated fatty acid ester is 1: 1～5;
Said reaction response medium comprises a kind of in tertiary amyl alcohol, acetonitrile or the tetrahydrofuran (THF);
Said unsaturated fatty acids comprises oleic acid, linolic acid, a kind of in linolic acid in distress, arachidonic acid, alpha-linolenic acid, timnodonic acid or the docosahexenoic acid (DHA) etc. altogether;
Said unsaturated fatty acid ester comprises a kind of in Witconol 2301, ethyl oleate, methyl linoleate, ethyl linoleate, EPA-EE, the docosahexenoic acid ethyl ester etc.;
Said immobilized lipase is selected from the lipase that derives from candiyeast, can adopt Journal ofMolecular Catalysis B:Enzymatic, 18 (2002) 261-266. document disclosed methods are prepared, or employing commercially available prod, the trade mark of producing as Novozymes Company is the immobilized lipase of Novozym 435, and this enzyme is that the Type B lipase of Candida antarctica is fixed on the propylene type macroporous resin.
In the nonaqueous phase enzyme catalysis, moisture is an important factors, and the enzyme molecule is kept its active configuration needs certain moisture, in addition, but polarity or wetting ability because of reaction solvent and carrier under identical water activity are different, and water activity is also different in the microenvironment of enzyme molecule.In the enzyme process of L-xitix linoleate is synthetic, we find, no matter be in transesterification or in ester synthesis reaction, water activity is all very big to the influence of productive rate, when containing a certain amount of moisture in the reaction system, water activity not only influences the activity of lipase in the transesterification reaction, and to the hydrolysis of the hydrolysis of substrate methyl linoleate, product and synthetic all influential, moisture can produce complicated influence to entire reaction.
The contriver is through a large amount of tests, find, the content of moisture is very remarkable to the influence of transformation efficiency and reaction efficiency in the reaction system, to moisture contents different in the reaction system, as be respectively 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1% etc. and test, the initial velocity of assaying reaction and reach balance after transformation efficiency.The result shows: moisture content is the initial velocity maximum when 0.04%-0.06%, and less than 0.03% o'clock transformation efficiency maximum.
Therefore, during reaction, at 0.04%-0.06%, and be controlled at below 0.03% after two hours, can under the situation that reduces reaction time, obtain maximum conversion rate like this preceding two hours moisture controlled
Adopt method of the present invention, in unsaturated fatty acids, transformation efficiency is more than 35%, and the reaction times can shorten to below 16 hours.
This shows that method of the present invention can obtain high transformation efficiency in the short reaction times, be a kind of method for preparing L-xitix unsaturated fatty acid ester with industrializing implementation prospect.
Description of drawings
Fig. 1 be in the reaction system moisture content to the influence of initial velocity of reaction and productive rate.
Fig. 2 is that different in moisture content influences the product synthetic.
Embodiment
Embodiment 1
Get the tool plug triangular flask of 50ml, in bottle, take by weighing the vitamins C of about 0.3g, take by weighing the 0.6g methyl linoleate.Add the 10ml tertiary amyl alcohol, add molecular sieve 1.0g.Sealing.Triangular flask is put into high temperature shaking table preheating 30 minutes (50 ℃ of high temperature shaking table temperature, 200rps), the trade mark that adds Novozymes Company's production is Novozym 435 immobilized lipase 0.3g, whole system moisture content is controlled at 0.06%, react after 2 hours, add molecular sieve 3g, whole system moisture content is controlled at 0.03%, reacted 10 hours, reaction finishes, and column chromatography for separation obtains the linolic acid Vc ester of 0.15g purity 92%.
Embodiment 2
Get the tool plug triangular flask of 50ml, in bottle, take by weighing the vitamins C of about 0.3g, take by weighing 0.6g oleic acid.Add the 10ml acetonitrile, add molecular sieve 2g.Sealing.Triangular flask is put into high temperature shaking table preheating 30 minutes (60 ℃ of high temperature shaking table temperature, 200rps), the trade mark that adds Novozymes Company's production is Novozym 435 immobilized lipase 0.3g, whole system moisture content is controlled at 0.05%, react after 3 hours, add molecular sieve 1.5g, whole system moisture content is controlled at 0.02%, reacted 8 hours, reaction finishes, and column chromatography for separation obtains 0.12g purity 92% above oleic acid Vc ester.
Embodiment 3
Get the reactor of 50ml, take by weighing the vitamins C of about 0.3g, take by weighing 0.6gDHA (purity is more than 85%).Add the 15ml tetrahydrofuran (THF), 40 ℃, 200 rev/mins stirrings, 30 minutes, the trade mark that adds Novozymes Company's production was Novozym 435 immobilized lipase 0.3g, utilized the dry control moisture that refluxes of reduction vaporization, the pressure of system is vacuum tightness 0.08～0.1Mpa, the system moisture content of making is controlled at 0.02%, reacts 16 hours, and reaction finishes, column chromatography for separation obtains 0.1g purity 92% above DHAVc ester.
Claims (9)
1.L-xitix unsaturated fatty acid ester enzyme is urged synthetic method, it is characterized in that, comprise the steps: L-xitix and unsaturated fatty acids or unsaturated fatty acid ester, in reaction medium, with the immobilized lipase is catalyzer, and in the reaction system, water-content is 0.01～0.06% by weight, 40～60 ℃ were reacted 1～16 hour, adopted conventional method to collect L-xitix unsaturated fatty acid ester then from reaction product.
2. method according to claim 1, it is characterized in that, comprise the steps: L-xitix and unsaturated fatty acids or unsaturated fatty acid ester, in reaction medium, with the immobilized lipase is catalyzer, and in the reaction system, water-content is 0.04%-0.06% by weight, 40～60 ℃ of reactions 1～3 hour, and then be reaction 2-16 hour under 0.01～0.04% the condition at water-content.
3. method according to claim 1 is characterized in that, adds molecular sieve in reaction system, and in the gross weight of L-xitix and unsaturated fatty acids or unsaturated fatty acid ester, the add-on of molecular sieve is 5～20wt%.
4. method according to claim 1 is characterized in that, adopts the moisture content in the dry backflow hierarchy of control of reduction vaporization.
5. method according to claim 1 is characterized in that, the mol ratio of L-xitix and unsaturated fatty acids or unsaturated fatty acid ester is 1: 1～5.
6. according to each described method of claim 1～5, it is characterized in that said reaction response medium comprises a kind of in tertiary amyl alcohol, acetonitrile or the tetrahydrofuran (THF).
7. according to each described method of claim 1～5, it is characterized in that said unsaturated fatty acids comprises oleic acid, linolic acid, a kind of in linolic acid in distress, arachidonic acid, alpha-linolenic acid, timnodonic acid or the docosahexenoic acid etc. altogether.
8. according to each described method of claim 1～5, it is characterized in that said unsaturated fatty acid ester comprises a kind of in Witconol 2301, ethyl oleate, methyl linoleate, ethyl linoleate, EPA-EE, the docosahexenoic acid ethyl ester.
9. according to each described method of claim 1～5, it is characterized in that said immobilized lipase is selected from the lipase that derives from candiyeast.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410053976 CN1629303A (en) | 2004-08-24 | 2004-08-24 | Enzymatic synthesis method for L-ascorbic acid unsaturated fatty acid ester |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410053976 CN1629303A (en) | 2004-08-24 | 2004-08-24 | Enzymatic synthesis method for L-ascorbic acid unsaturated fatty acid ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1629303A true CN1629303A (en) | 2005-06-22 |
Family
ID=34846164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410053976 Pending CN1629303A (en) | 2004-08-24 | 2004-08-24 | Enzymatic synthesis method for L-ascorbic acid unsaturated fatty acid ester |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1629303A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010130139A1 (en) * | 2009-05-11 | 2010-11-18 | 江南大学 | Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof |
| CN104177318A (en) * | 2014-09-02 | 2014-12-03 | 石家庄康诺生物技术有限公司 | L-ascorbic acid-6-(10-hydroxyl-2-caproleic acid) esters or derivatives thereof and application of esters or derivatives |
| CN104262302A (en) * | 2014-09-02 | 2015-01-07 | 石家庄康诺生物技术有限公司 | L-ascorbic acid-6-(E-2-caproleic acid)ester or derivatives thereof and application thereof |
| CN104610201A (en) * | 2014-12-19 | 2015-05-13 | 暨南大学 | L-ascorbyl ricinoleate, and preparing method and applications thereof |
-
2004
- 2004-08-24 CN CN 200410053976 patent/CN1629303A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010130139A1 (en) * | 2009-05-11 | 2010-11-18 | 江南大学 | Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof |
| CN104177318A (en) * | 2014-09-02 | 2014-12-03 | 石家庄康诺生物技术有限公司 | L-ascorbic acid-6-(10-hydroxyl-2-caproleic acid) esters or derivatives thereof and application of esters or derivatives |
| CN104262302A (en) * | 2014-09-02 | 2015-01-07 | 石家庄康诺生物技术有限公司 | L-ascorbic acid-6-(E-2-caproleic acid)ester or derivatives thereof and application thereof |
| CN104177318B (en) * | 2014-09-02 | 2016-05-04 | 石家庄康诺生物技术有限公司 | L-AA-6-(10-hydroxyl-2-decylenic acid) ester or derivatives thereof and their application |
| CN104262302B (en) * | 2014-09-02 | 2016-05-11 | 石家庄康诺生物技术有限公司 | L-AA-6-(E-2-decylenic acid) ester or derivatives thereof and their application |
| CN104610201A (en) * | 2014-12-19 | 2015-05-13 | 暨南大学 | L-ascorbyl ricinoleate, and preparing method and applications thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110331139B (en) | A kind of immobilization method of Candida Antarctica lipase B | |
| CN103060394B (en) | Method of glycerolysis reaction for preparing partial glyceride | |
| Eleveld et al. | Enantioselective deprotonation of two racemic cyclic carbonyl compounds by a chiral lithium amide | |
| JPH03228694A (en) | Production of optically active hydroxylactones | |
| CN1629303A (en) | Enzymatic synthesis method for L-ascorbic acid unsaturated fatty acid ester | |
| CN101104861B (en) | Method for preparing S-ibuprofen and S-ibuprofen ester by biological catalysis | |
| CN101215587B (en) | Solvent-free system biological catalysis fast synthesis method for feruloylated glycerol | |
| CN114875015A (en) | Preparation method of lipase-polymer conjugate and application of lipase-polymer conjugate in structural lipid transesterification | |
| CN101638676B (en) | Manufacturing method of polyunsaturated fatty acid triglycercide | |
| Torres et al. | Part II. Two enzymatic procedures for the selective synthesis of malic acid monoesters | |
| RU2095415C1 (en) | Method of preparing ethanol from cellulose material | |
| CN101392272A (en) | A kind of method for enzymatically synthesizing caffeic acid phenethyl ester in a solvent-free system | |
| CN102120977A (en) | Microbacterium chocolatum and method for preparing (4S,5R)-half ester by using same | |
| CN1778889A (en) | Bacteria and method for preparing (S)-4-chloro-3-hydroxybutyrate by biocatalysis | |
| CN118291556B (en) | Process for producing lactic acid by straw | |
| CN113234609A (en) | Special strain for synthesizing fructo-oligosaccharide and method for synthesizing fructo-oligosaccharide by using special strain | |
| Soccol et al. | Flavor production by solid and liquid fermentation | |
| CN117646043B (en) | A method for simultaneously preparing monoglyceride rich in palmitoleic acid and diglyceride rich in oleic acid | |
| CN120400266B (en) | A method for preparing a weight-loss glycerol oil and its application | |
| CN112877383B (en) | Immobilized lipase catalyzed citric acid functionalized beta-cyclodextrin and preparation method thereof | |
| CN118879797B (en) | A method for preparing diglyceride oil | |
| CN114231571B (en) | Production method for synthesizing monoglyceride stearate by immobilized composite lipase catalysis | |
| CN110607240B (en) | Ganoderma lucidum extract and method for catalyzing 5-hydroxymethylfurfural reaction by using same | |
| CN121472340A (en) | Method for preparing medium-chain fatty glyceride by double-enzyme method | |
| CN120700068A (en) | Application of a low-temperature lipase in the preparation of diglycerides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20050622 |